---
$id: https://graph.org.ai/products/commodity/51171823
$type: Product
source: UNSPSC
code: "51171823"
title: "Granisetron"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Granisetron

**UNSPSC Code**: 51171823
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a 5-ht3 receptor antagonist with the molecular formula C18H24N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WZG3J2MCOL, chemically known as 1h-indazole-3-carboxamide, 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, endo- but generally known as granisetron, which bears US NIH Compound Identifier 3510. European Medicines Agency schedules Granisetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07964MIG. The term GRANISETRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules granisetron in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule granisetron under HS 29399900 and SITC 54149. As of Q4 2014, GRANISETRON remains the US FDA Preferred Term for this commodity. Granisetron bears US NLM identifiers UMLS ID C0061863 and NCI Concept Code C62031. SMILES: O=C(NC1CC2N(C(C1)CCC2)C)C1NN(C2C1CCCC2)C.

